AtaiBeckley (ATAI) Consolidated Net Income (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Consolidated Net Income came in at -$61.1 million in Q3 2025, down 132.44% year-on-year from $188.3 million in Q3 2024, and down 120.15% quarter-over-quarter from -$27.8 million in Q2 2025.

AtaiBeckley (ATAI) Consolidated Net Income (2020 - 2026) Analysis & Trends

AtaiBeckley's Consolidated Net Income history runs 2 years deep, the most recent figure standing at -$30.0 million for Q1 2026.

  • In Q1 2026, Consolidated Net Income fell 13.29% year-over-year to -$30.0 million; the TTM figure through Mar 2026 stood at -$56.4 million (changed N/A YoY), while the FY2025 annual figure was -$660.1 million, down 344.83% from the prior year.
  • Consolidated Net Income came in at -$61.1 million for Q3 2025 at AtaiBeckley, down from -$27.8 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$26.5 million in Q1 2025 to a low of -$30.0 million in Q1 2026.
  • The 5-year median for Consolidated Net Income is -$31.9 million (2023), against an average of -$30.7 million.
  • Across the five-year window, Consolidated Net Income plunged 842.61% in 2021 and jumped 231.08% in 2023, its largest moves.
  • AtaiBeckley's Consolidated Net Income stood at -$52.1 million in 2021, then gained by 13.07% to -$45.3 million in 2022, then jumped by 63.12% to -$16.7 million in 2023, then tumbled by 135.34% to -$39.3 million in 2024, then tumbled by 55.31% to -$61.1 million in 2025.
  • The last three Consolidated Net Income figures came in at -$61.1 million (Q3 2025), -$27.8 million (Q2 2025), and -$26.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - -29.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.98 Mn
Sep 30, 2025 -61.10 Mn
Jun 30, 2025 -27.75 Mn
Mar 31, 2025 -26.47 Mn
Mar 31, 2025 -26.47 Mn
Dec 31, 2024 -39.34 Mn
Sep 30, 2024 -26.29 Mn
Jun 30, 2024 -57.18 Mn
Mar 31, 2024 -25.68 Mn
Dec 31, 2023 -16.72 Mn
Sep 30, 2023 43.61 Mn
Jun 30, 2023 -31.86 Mn
Mar 31, 2023 -33.36 Mn
Dec 31, 2022 -45.32 Mn
Sep 30, 2022 -33.27 Mn
Jun 30, 2022 -30.86 Mn
Mar 31, 2022 -31.96 Mn
Dec 31, 2021 -52.14 Mn
Sep 30, 2021 -26.87 Mn
Jun 30, 2021 -67.36 Mn